MULLERIAN INHIBITING SUBSTANCE AS A MARKER FOR OVARIAN SEX-CORD TUMOR

被引：106

作者：

GUSTAFSON, ML

LEE, MM

SCULLY, RE

MONCURE, AC

HIRAKAWA, T

GOODMAN, A

MUNTZ, HG

DONAHOE, PK

MACLAUGHLIN, DT

FULLER, AF

机构：

[1] MASSACHUSETTS GEN HOSP,PEDIAT SURG RES LAB,WARREN 11,BOSTON,MA 02114

[2] MASSACHUSETTS GEN HOSP,VINCENT RES LAB,BOSTON,MA 02114

[3] MASSACHUSETTS GEN HOSP,DEPT SURG,BOSTON,MA 02114

[4] MASSACHUSETTS GEN HOSP,DEPT PEDIAT,BOSTON,MA 02114

[5] MASSACHUSETTS GEN HOSP,DEPT PATHOL,BOSTON,MA 02114

[6] MASSACHUSETTS GEN HOSP,DEPT OBSTET & GYNECOL,BOSTON,MA 02114

[7] HARVARD UNIV,SCH MED,BOSTON,MA 02115

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1992年 / 326卷 / 07期

关键词：

D O I：

10.1056/NEJM199202133260707

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

MüLLERIAN inhibiting substance is a glycoprotein hormone produced by fetal Sertoli cells that causes regression of the müllerian ducts in males during sexual differentiation.1 2 3 Serum concentrations of this hormone remain high in boys for several years, but then decline by puberty.4 During normal female development, in the absence of müllerian inhibiting substance, the müllerian ducts give rise to the fallopian tubes, uterus, and upper third of the vagina.1 Postnatally, granulosa cells also secrete this hormone,5 resulting in serum concentrations in pubertal girls and women that are similar to those in men. A potential role for müllerian inhibiting substance in the. . . © 1992, Massachusetts Medical Society. All rights reserved.

引用

页码：466 / 471

页数：6

共 27 条

[1] AHN GH, 1986, CANCER, V57, P1066, DOI 10.1002/1097-0142(19860301)57:5<1066::AID-CNCR2820570534>3.0.CO
[2] 2-C
[3] [Anonymous], ARCH ANAT MICR MORPH
[4] AN IMPROVED METHOD OF PURIFYING INHIBIN RADIOLIGAND FOR RADIOIMMUNOASSAY
BERNSTEIN, JR
CROWLEY, WF
SCHNEYER, AL
[J]. BIOLOGY OF REPRODUCTION, 1990, 43 (03) : 492 - 496
[5] ISOLATION OF THE BOVINE AND HUMAN GENES FOR MULLERIAN INHIBITING SUBSTANCE AND EXPRESSION OF THE HUMAN-GENE IN ANIMAL-CELLS
CATE, RL
MATTALIANO, RJ
HESSION, C
TIZARD, R
FARBER, NM
CHEUNG, A
NINFA, EG
FREY, AZ
GASH, DJ
CHOW, EP
FISHER, RA
BERTONIS, JM
TORRES, G
WALLNER, BP
RAMACHANDRAN, KL
RAGIN, RC
MANGANARO, TF
MACLAUGHLIN, DT
DONAHOE, PK
[J]. CELL, 1986, 45 (05) : 685 - 698
[6] CATE RL, 1990, HDB EXPT PHARM PEPTI, V95, P179
[7] METABOLIC-CLEARANCE AND PRODUCTION-RATES OF PROLACTIN IN MAN
COOPER, DS
RIDGWAY, EC
KLIMAN, B
KJELLBERG, RN
MALOOF, F
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (06) : 1669 - 1680
[8] GRADED ORGAN-CULTURE ASSAY FOR DETECTION OF MULLERIAN INHIBITING SUBSTANCE
DONAHOE, PK
ITO, Y
HENDREN, WH
[J]. JOURNAL OF SURGICAL RESEARCH, 1977, 23 (02) : 141 - 148
[9] DONAHOE PK, 1987, RECENT PROG HORM RES, V43, P431
[10] NEUROENDOCRINE REGULATION OF THE CORPUS-LUTEUM IN THE HUMAN - EVIDENCE FOR PULSATILE PROGESTERONE SECRETION
FILICORI, M
BUTLER, JP
CROWLEY, WF
[J]. JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (06) : 1638 - 1647

← 1 2 3 →